Table 1 Association between FERMT1 expression and clinicopathological characteristics in NPC patients
Characteristics | Total | High expression FERMT1 | P value |
|---|---|---|---|
Number, n (%) | – | ||
Tumor tissues | 109 | 54(49.5) | 0.016 |
Non | 10 | 1 | |
Age (years) (n[%]) | |||
< 60 | 92 | 46 | 0.824 |
≥ 60 | 17 | 8 | |
Gender (n [%]) | |||
Female | 33 | 12 | 0.07 |
Male | 76 | 42 | |
T classification | 0.001 | ||
T1–2 | 42 | 12 | |
T1 | 14 | 3 | |
T2 | 28 | 9 | |
T3–4 | 67 | 42 | |
T3 | 35 | 24 | |
T4 | 32 | 18 | |
N classification | |||
N0–1 | 39 | 16 | 0.184 |
N0 | 12 | 3 | |
N1 | 27 | 13 | |
N2–3 | 70 | 38 | |
M classification | 0.035 | ||
M0 | 96 | 44 | |
M1 | 13 | 10 | |
Clinical stage | 0.001 | ||
I–II | 20 | 3 | |
III–IV | 89 | 51 | |
Histologic subtypes | 0.403 | ||
WHO type I | 1 | 1 | |
WHO type II | 11 | 4 | |
WHO type III | 97 | 49 | |